United Therapeutics Corp.
Asset & Liabilities Breakdown
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
FY2019
FY2018
FY2017
FY2016
FY2015
FY2014
FY2013
FY2012
FY2011
FY2010
FY2009
Asset Breakdown FY2016
Total Assets: $2.33B
Liabilities Breakdown FY2016
Total Liabilities: $463.4M
Asset Breakdown
Total Assets: $2.33B
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.02B | 44.0% |
| Accounts Receivable | $214.5M | 9.2% |
| Inventory | $100.0M | 4.3% |
| Property, Plant & Equipment | $489.3M | 21.0% |
| Goodwill | $10.3M | 0.4% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $488.5M | 21.0% |
Liabilities Breakdown
Total Liabilities: $463.4M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $8.1M | 1.7% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $455.3M | 98.3% |